PayPal reported Q2 earnings on July 28 and immediately triggered the largest single-day analyst target revision wave of the year — an unmistakable sign that the Street was underpositioned heading into the print.
Every analyst who moved on July 29 raised their target. JP Morgan's Tien-Tsin Huang lifted his price objective from $46 to $65, a 41% revision on a Neutral rating. RBC Capital moved to $65 from $59, maintaining Outperform. Keefe, Bruyette & Woods raised to $70 from $55, also keeping Outperform. Wells Fargo, BMO, Macquarie, Citigroup, and Mizuho all followed suit — universally higher targets, universally unchanged ratings. The pattern is telling: analysts are marking up fair value aggressively while declining to upgrade conviction. The consensus stays at Hold, with 31 of that designation in the tally, and the new mean target of roughly $57.65 is almost exactly where the stock is already trading at $58.32. The Street is, again, playing catch-up rather than leading.
The positioning picture is quiet relative to the drama on the analyst side. Short interest, running at 5.6% of the free float, has eased about 3% on the week and is down from a recent peak above 5.5 million shares higher in mid-July. Borrow is cheap — cost to borrow is around 0.41%, down nearly 19% on the week — and availability is exceptionally loose at 1,712%, meaning the lending pool holds roughly 17 shares available for every one already borrowed. There is no squeeze mechanic here, no trapped short. The shorts unwinding are doing so cleanly and without friction. The ORTEX short score has drifted lower all week, sitting at 41.5, consistent with a stock where bear conviction is fading rather than building.
Options traders leaned into the rally rather than hedging it. The put/call ratio fell to 0.38 on Tuesday — near the 52-week low of 0.35 and roughly 1.4 standard deviations below the 20-day average of 0.41. That is the second consecutive week where the PCR has run below the mean, a shift that began as the stock started to break above prior bear-case price targets in mid-July. The earlier earnings preview note flagged this same setup: options positioning was unusually call-heavy even before the print, and the earnings beat has reinforced that tilt. There is no sign of defensive hedging entering the picture.
On valuation, the stock now trades at roughly 10.5x trailing earnings and 7.7x EV/EBITDA — multiples that have expanded meaningfully over the past month as the price has re-rated 32% higher. The price-to-book has climbed to 2.3x. None of these are stretched for a payments franchise of this scale, but the compression in the earnings yield (down nearly 3 percentage points over 30 days) reflects how quickly the cheap-valuation thesis has been harvested. The EV/EBIT factor score still ranks in the 73rd percentile, which gives the bulls room to argue the stock is not expensive, but EPS momentum scores — at 32 for the 30-day reading and 33 for the 90-day — suggest estimate revisions have been running below the broader universe. The earnings beat may change that trajectory when the next consensus refresh lands. Among peers, PAY surged 15% on the week and FIS added 8%, suggesting the payments sector broadly caught a bid — PayPal's 4.4% weekly gain trails those names, an unusual inversion given the company was the one reporting.
Institutional data, current through June 30, shows BlackRock adding roughly 3.7 million shares in the most recent period, lifting its stake to 8.35% of shares outstanding. Amundi nearly doubled its position, adding 9.3 million shares to reach 1.57% of the company. Geode added 4.7 million shares. The aggregate picture is of passive and semi-active managers building weight into what had been a deeply out-of-favour large-cap — a positioning change that pre-dated the July rally and may have contributed to it.
The next earnings date is October 27. Between now and then, the question worth watching is whether the analyst community — still overwhelmingly parked at Hold — begins upgrading ratings to match the target increases it filed this week, or whether the stock needs to pull back toward the new consensus target before conviction improves.
See the live data behind this article on ORTEX.
Open PYPL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
